Quest Partners LLC Buys Shares of 2,278 Liquidia Co. (NASDAQ:LQDA)

Quest Partners LLC purchased a new position in shares of Liquidia Co. (NASDAQ:LQDA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,278 shares of the company’s stock, valued at approximately $27,000.

A number of other institutional investors also recently made changes to their positions in LQDA. Trexquant Investment LP purchased a new stake in Liquidia during the 4th quarter worth about $770,000. California State Teachers Retirement System boosted its stake in shares of Liquidia by 491.2% during the 1st quarter. California State Teachers Retirement System now owns 46,181 shares of the company’s stock worth $681,000 after purchasing an additional 38,369 shares during the last quarter. Vestal Point Capital LP acquired a new stake in shares of Liquidia during the 4th quarter worth about $12,331,000. Kynam Capital Management LP grew its holdings in shares of Liquidia by 34.9% during the fourth quarter. Kynam Capital Management LP now owns 2,698,324 shares of the company’s stock worth $32,461,000 after buying an additional 698,324 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its position in shares of Liquidia by 119.4% in the first quarter. BNP Paribas Financial Markets now owns 230,248 shares of the company’s stock valued at $3,396,000 after buying an additional 125,315 shares during the last quarter. 64.54% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on LQDA shares. Needham & Company LLC restated a “buy” rating and set a $25.00 target price on shares of Liquidia in a research report on Monday, August 19th. Bank of America decreased their price objective on Liquidia from $24.00 to $23.00 and set a “buy” rating on the stock in a report on Tuesday, August 20th. HC Wainwright lowered their price objective on Liquidia from $32.00 to $29.00 and set a “buy” rating for the company in a research report on Tuesday, August 20th. BTIG Research reduced their target price on Liquidia from $29.00 to $25.00 and set a “buy” rating on the stock in a research report on Monday, August 19th. Finally, Oppenheimer assumed coverage on Liquidia in a report on Tuesday, June 25th. They issued a “market perform” rating for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $23.14.

Insider Transactions at Liquidia

In other Liquidia news, Director Caligan Partners Lp bought 150,000 shares of Liquidia stock in a transaction that occurred on Friday, August 30th. The shares were acquired at an average price of $9.51 per share, for a total transaction of $1,426,500.00. Following the acquisition, the director now owns 6,994,997 shares of the company’s stock, valued at approximately $66,522,421.47. The acquisition was disclosed in a filing with the SEC, which is available at this link. In related news, Director Caligan Partners Lp purchased 150,000 shares of Liquidia stock in a transaction that occurred on Friday, August 30th. The shares were purchased at an average cost of $9.51 per share, with a total value of $1,426,500.00. Following the transaction, the director now owns 6,994,997 shares of the company’s stock, valued at approximately $66,522,421.47. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Michael Kaseta sold 3,906 shares of the company’s stock in a transaction that occurred on Friday, July 12th. The stock was sold at an average price of $12.53, for a total value of $48,942.18. Following the completion of the transaction, the chief financial officer now owns 312,389 shares of the company’s stock, valued at approximately $3,914,234.17. The disclosure for this sale can be found here. Insiders sold 21,422 shares of company stock valued at $256,998 over the last 90 days. Corporate insiders own 31.60% of the company’s stock.

Liquidia Price Performance

Shares of NASDAQ:LQDA opened at $9.95 on Friday. The business has a 50-day moving average of $10.75 and a two-hundred day moving average of $12.54. The firm has a market capitalization of $760.32 million, a PE ratio of -6.38 and a beta of 0.22. Liquidia Co. has a 12 month low of $5.71 and a 12 month high of $16.99.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.02). The business had revenue of $3.66 million during the quarter, compared to analysts’ expectations of $7.92 million. Liquidia had a negative net margin of 755.46% and a negative return on equity of 183.57%. As a group, research analysts anticipate that Liquidia Co. will post -1.69 earnings per share for the current year.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).